Evidence map›Paper›PMID 27479298›Full record

ArticleJournal of medical virology2016

Genotypes of rubella virus and the epidemiology of rubella infections in the Democratic Republic of the Congo, 2004-2013.

Elizabeth Pukuta, Diane Waku-Kouomou, Emily Abernathy, Benoit Kebela Illunga, Ricardo Obama, Vital Mondonge, Benjamin A Dahl, Balcha G Maresha, Joseph Icenogle, Jean-Jacques Muyembe

Abstract read
In one paragraph

Article in Journal of medical virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Elizabeth PukutaInstitut National de Recherches Biomédicales, Kinshasa, Democratic Republic of the Congo.
Diane Waku-KouomouDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, United States Centers for Disease Control and Prevention, Atlanta, Georgia.
Emily AbernathyDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, United States Centers for Disease Control and Prevention, Atlanta, Georgia.
Benoit Kebela IllungaOffice of Disease Prevention, Ministry of Public Health, Kinshasa, Democratic Republic of the Congo.
Ricardo ObamaExpanded Program on Immunization, World Health Organization, Kinshasa, Democratic Republic of the Congo.
Vital MondongeWorld Health Organization, Kinshasa, Democratic Republic of the Congo.
Benjamin A DahlGlobal Immunization Division, Center for Global Health, United States Centers for Disease Control and Prevention, Atlanta, Georgia.
Balcha G MareshaImmunization and Vaccines Development, World Health Organization African Regional Office, Brazzaville, Democratic Republic of the Congo.
Joseph IcenogleDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, United States Centers for Disease Control and Prevention, Atlanta, Georgia.
Jean-Jacques MuyembeInstitut National de Recherches Biomédicales, Kinshasa, Democratic Republic of the Congo.
Centers for Disease Control and Prevention · USNational Institute of Biomedical Research · CDMinistry of Public Health · CDWorld Health Organization Regional Office for Africa · CG

Funding

Intramural CDC HHS CC999999World Health Organization 001
6 · The paper itself

Abstract

Rubella is a viral infection that may cause fetal death or congenital defects, known as congenital rubella syndrome (CRS), during early pregnancy. The World Health Organization (WHO) recommends that countries assess the burden of rubella and CRS, including the determination of genotypes of circulating viruses. The goal of this study was to identify the genotypes of rubella viruses in the Democratic Republic of the Congo (DRC). Serum or throat swab samples were collected through the measles surveillance system. Sera that tested negative for measles IgM antibody were tested for rubella IgM antibody. Serum collected within 4 days of rash onset and throat swabs were screened by real-time RT-PCR for rubella virus RNA. For positive samples, an amplicon of the E1 glycoprotein gene was amplified by RT-PCR and sequenced. 11733 sera were tested for rubella IgM and 2816 (24%) were positive; 145 (5%) were tested for the presence of rubella RNA by real-time RT-PCR and 10 (7%) were positive. Seventeen throat swabs were analyzed by RT-PCR and three were positive. Sequences were obtained from eight of the positive samples. Phylogenetic analysis showed that the DRC rubella viruses belonged to genotypes 1B, 1E, 1G, and 2B. This report provides the first information on the genotypes of rubella virus circulating in the DRC. These data contribute to a better understanding of rubella burden and the dynamics of rubella virus circulation in Africa. Efforts to establish rubella surveillance in the DRC are needed to support rubella elimination in Africa. J. Med. Virol. 88:1677-1684, 2016. © 2016 Wiley Periodicals, Inc.

Indexed as

AdolescentAdultAntibodies, ViralChildChild, PreschoolCost of IllnessDemocratic Republic of the CongoFemaleGenotypeHumansImmunoglobulin MInfantInfant, NewbornMaleMeaslesMeasles virusAntibodies, ViralE1 envelope protein, Rubella virusImmunoglobulin MRNA, ViralViral Envelope ProteinsAfricaDRCgenotypingrubella

Identifiers

PMID27479298
PMCPMC5712459
OpenAlexW2294992789

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.